{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:37:53Z","timestamp":1790948273627,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"am","delay-in-days":258,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.neuropharm.2024.110035","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T09:20:44Z","timestamp":1718270444000},"page":"110035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The PDE4 inhibitor apremilast modulates ethanol responses in Gabrb1-S409A knock-in mice via PKA-dependent and independent mechanisms"],"prefix":"10.1016","volume":"257","author":[{"given":"Yuri A.","family":"Blednov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Shawlot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg E.","family":"Homanics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-137X","authenticated-orcid":false,"given":"Elizabeth A.","family":"Osterndorff-Kahanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Mayfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Smalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5345-4431","authenticated-orcid":false,"given":"Robert O.","family":"Messing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110035_bib1","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/j.1471-4159.2007.04982.x","article-title":"Replacement of histidine in position 105 in the alpha(5) subunit by cysteine stimulates zolpidem sensitivity of alpha(5)beta(2)gamma(2) GABA(A) receptors","volume":"103","author":"Baur","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110035_bib2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nbt1240","article-title":"A probability-based approach for high-throughput protein phosphorylation analysis and site localization","volume":"24","author":"Beausoleil","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2024.110035_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2012.10.016","article-title":"Linking GABA(A) receptor subunits to alcohol-induced conditioned taste aversion and recovery from acute alcohol intoxication","volume":"67","author":"Blednov","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110035_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnins.2014.00129","article-title":"Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL\/6J mice","volume":"8","author":"Blednov","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110035_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108220","article-title":"Apremilast regulates acute effects of ethanol and other GABAergic drugs via protein kinase A-dependent signaling","volume":"178","author":"Blednov","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110035_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109255","article-title":"Apremilast-induced increases in acute ethanol intoxication and decreases in ethanol drinking in mice involve PKA phosphorylation of GABAA beta3 subunits","volume":"220","author":"Blednov","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110035_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/acer.13615","article-title":"Apremilast alters behavioral responses to ethanol in mice: II. Increased sedation, intoxication, and reduced acute functional tolerance","volume":"42","author":"Blednov","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2024.110035_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/acer.13616","article-title":"Apremilast alters behavioral responses to ethanol in mice: I. Reduced consumption and preference","volume":"42","author":"Blednov","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2024.110035_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2016.01.009","article-title":"Differential regulation of synaptic and extrasynaptic alpha4 GABA(A) receptor populations by protein kinase A and protein kinase C in cultured cortical neurons","volume":"105","author":"Bohnsack","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110035_bib10","doi-asserted-by":"crossref","first-page":"15230","DOI":"10.1073\/pnas.0604304103","article-title":"GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol","volume":"103","author":"Chandra","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2024.110035_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1530-0277.2007.00563.x","article-title":"Normal acute behavioral responses to moderate\/high dose ethanol in GABAA receptor alpha 4 subunit knockout mice","volume":"32","author":"Chandra","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2024.110035_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1017404","article-title":"Analyzing the mechanisms that facilitate the subtype-specific assembly of gamma-aminobutyric acid type A receptors","volume":"15","author":"Choi","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110035_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/24884","article-title":"Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP","volume":"396","author":"de Rooij","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.110035_bib14","first-page":"1310","article-title":"Genetic selection and characterization of mouse lines for acute functional tolerance to ethanol","volume":"279","author":"Erwin","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110035_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110035_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159103","article-title":"Pre-clinical and clinical evidence for suppression of alcohol intake by apremilast","author":"Grigsby","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2024.110035_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13059-016-1012-2","article-title":"Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR","volume":"17","author":"Haeussler","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuropharm.2024.110035_bib18","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1021\/bi00316a032","article-title":"Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C","volume":"23","author":"Hidaka","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2024.110035_bib19","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.282.5397.2275","article-title":"A family of cAMP-binding proteins that directly activate Rap1","volume":"282","author":"Kawasaki","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2024.110035_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pbb.2006.07.007","article-title":"Pharmacological and genetic influences on hole-board behaviors in mice","volume":"85","author":"Kliethermes","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2024.110035_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnins.2012.00044","article-title":"Ethanol activation of protein kinase A regulates GABA(A) receptor subunit expression in the cerebral cortex and contributes to ethanol-induced hypnosis","volume":"6","author":"Kumar","year":"2012","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110035_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10519-022-10102-1","article-title":"The hole-board test in mutant mice","volume":"52","author":"Lalonde","year":"2022","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2024.110035_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1530-0277.2007.00564.x","article-title":"Functional consequences of GABAA receptor alpha 4 subunit deletion on synaptic and extrasynaptic currents in mouse dentate granule cells","volume":"32","author":"Liang","year":"2008","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2024.110035_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80747","article-title":"Epac2 in midbrain dopamine neurons contributes to cocaine reinforcement via enhancement of dopamine release","volume":"11","author":"Liu","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2024.110035_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2024.110035_bib26","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1021\/acs.jmedchem.9b01312","article-title":"Subtype selective gamma-aminobutyric acid type A receptor (GABA(A)R) modulators acting at the benzodiazepine binding site: an update","volume":"63","author":"Maramai","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.110035_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/223","article-title":"Adjacent phosphorylation sites on GABAA receptor beta subunits determine regulation by cAMP-dependent protein kinase","volume":"1","author":"McDonald","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110035_bib28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1530-0277.2010.01383.x","article-title":"Intermittent (every-other-day) drinking induces rapid escalation of ethanol intake and preference in adolescent and adult C57BL\/6J mice","volume":"35","author":"Melendez","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2024.110035_bib29","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1016\/S0021-9258(19)49736-6","article-title":"Identification of the cAMP-dependent protein kinase and protein kinase C phosphorylation sites within the major intracellular domains of the beta 1, gamma 2S, and gamma 2L subunits of the gamma-aminobutyric acid type A receptor","volume":"267","author":"Moss","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110035_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.1323140","article-title":"Functional modulation of GABAA receptors by cAMP-dependent protein phosphorylation","volume":"257","author":"Moss","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2024.110035_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.apha.2014.11.008","article-title":"Regulation of GABAARs by phosphorylation","volume":"72","author":"Nakamura","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110035_bib32","doi-asserted-by":"crossref","first-page":"12330","DOI":"10.1074\/jbc.RA120.014303","article-title":"Phosphorylation on Ser-359 of the alpha2 subunit in GABA type A receptors down-regulates their density at inhibitory synapses","volume":"295","author":"Nakamura","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2024.110035_bib33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1037\/0033-2909.108.3.383","article-title":"Alcohol challenge with sons of alcoholics: a critical review and analysis","volume":"108","author":"Newlin","year":"1990","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuropharm.2024.110035_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.isci.2019.11.013","article-title":"cAMP-EPAC-dependent regulation of gephyrin phosphorylation and GABA(A)R trapping at inhibitory synapses","volume":"22","author":"Niwa","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.neuropharm.2024.110035_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13075-015-0771-6","article-title":"Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors","volume":"17","author":"Perez-Aso","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.neuropharm.2024.110035_bib36","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2024.110035_bib37","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.celrep.2016.02.018","article-title":"Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-cas9 nucleases","volume":"14","author":"Renaud","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2024.110035_bib38","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1369-1600.2012.00481.x","article-title":"Escalation of intake under intermittent ethanol access in diverse mouse genotypes","volume":"18","author":"Rosenwasser","year":"2013","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2024.110035_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(02)02191-X","article-title":"Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes","volume":"451","author":"Sanna","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110035_bib40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/acer.13628","article-title":"A critical review of methods and results in the search for genetic contributors to alcohol sensitivity","volume":"42","author":"Schuckit","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2024.110035_bib41","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International union of basic and clinical pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110035_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s42003-022-04381-x","article-title":"Spectrin-beta 2 facilitates the selective accumulation of GABA(A) receptors at somatodendritic synapses","volume":"6","author":"Smalley","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuropharm.2024.110035_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.563091","article-title":"Isolation and characterization of multi-protein complexes enriched in the K-Cl Co-transporter 2 from brain plasma membranes","volume":"13","author":"Smalley","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110035_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-2999(98)00223-4","article-title":"Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and\/or anxiolytic state in mice","volume":"350","author":"Takeda","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110035_bib45","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1152\/jn.00801.2009","article-title":"Modulation of spontaneous and GABA-evoked tonic alpha4beta3delta and alpha4beta3gamma2L GABAA receptor currents by protein kinase A","volume":"103","author":"Tang","year":"2010","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2024.110035_bib46","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/1568026799078787","article-title":"The GABAA-BZR complex as target for the development of anxiolytic drugs","volume":"12","author":"Trincavelli","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.110035_bib47","doi-asserted-by":"crossref","first-page":"14805","DOI":"10.1073\/pnas.1514657112","article-title":"Compromising the phosphodependent regulation of the GABAAR beta3 subunit reproduces the core phenotypes of autism spectrum disorders","volume":"112","author":"Vien","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2024.110035_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/jpet.106.106161","article-title":"Knockin mice with ethanol-insensitive alpha1-containing gamma-aminobutyric acid type A receptors display selective alterations in behavioral responses to ethanol","volume":"319","author":"Werner","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T18:11:30Z","timestamp":1723572690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824002041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":48,"alternative-id":["S0028390824002041"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110035","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The PDE4 inhibitor apremilast modulates ethanol responses in Gabrb1-S409A knock-in mice via PKA-dependent and independent mechanisms","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110035"}}